Education
About Us
Working with TipRanks
Follow Us
SIXL - ETF AI Analysis
Top Page
ETC 6 Meridian Low Beta Equity ETF (SIXL)
Rating:70Neutral
Price Target:―
Positive Factors
Broad Sector Diversification
The fund spreads its investments across many sectors like utilities, consumer defensive, health care, financials, and real estate, which can help reduce the impact if any one area of the market struggles.
Generally Strong Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, suggesting its low-beta approach has been working in the current market.
Multiple Strong-Performing Top Holdings
Several of the largest positions, including Royal Gold, Caci International, Madison Square Garden Sports, Dollar General, and Monster Beverage, have delivered strong year-to-date results that support the fund’s overall performance.
Negative Factors
High U.S. Market Concentration
Almost all of the ETF’s assets are invested in U.S. companies, so it offers very little geographic diversification outside the United States.
Moderately High Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which means more of the returns are used to cover fees instead of going to investors.
Some Lagging Holdings
At least one top holding, such as Protagonist Therapeutics, has shown weak year-to-date performance, which can drag on the fund’s overall results.
SIXL vs. SPDR S&P 500 ETF (SPY)
AUM192.14M
RegionNorth America
Expense Ratio0.47%
Beta0.35
IssuerMeridian
Inception DateMay 11, 2020
Dividend Yield2.31%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume4,057
30 Day Avg. Volume4,990
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
43.53Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering241
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SIXL Summary
SIXL, the ETC 6 Meridian Low Beta Equity ETF, is a U.S. stock fund that aims to hold companies that tend to move less than the overall market. It doesn’t track a specific index, but follows a “low beta” theme, focusing on steadier sectors like utilities, consumer defensive, and health care. Well-known holdings include Dollar General and Monster Beverage. Someone might invest in SIXL to seek stock market growth with smoother ups and downs and broad diversification across many industries. A key risk is that it can still lose value and will go up and down with the stock market over time.
How much will it cost me?The ETC 6 Meridian Low Beta Equity ETF (Ticker: SIXL) has an expense ratio of 0.47%, meaning you’ll pay $4.70 per year for every $1,000 invested. This is slightly higher than average because it is actively managed, focusing on selecting low beta stocks to reduce market volatility. This strategy requires more research and management compared to passively managed funds.
What would affect this ETF?The SIXL ETF, with its focus on low beta equities and strong exposure to sectors like Utilities, Consumer Defensive, and Health Care, could benefit from economic stability or increased demand for defensive stocks during market uncertainty. However, it may face challenges if interest rates rise, as sectors like Real Estate and Utilities are sensitive to borrowing costs, or if growth-oriented sectors like Technology underperform. Its U.S.-centric exposure also ties its performance closely to domestic economic conditions and regulatory changes.
SIXL Top 10 Holdings
SIXL is quietly powered by a mix of steady, lower-volatility names rather than flashy mega-caps. Recent strength from Lockheed Martin, International Seaways, and EZCORP has been doing much of the heavy lifting, with Royal Gold also adding a solid tailwind after a strong run. On the softer side, Casella Waste has been more of a speed bump, with performance looking mixed lately. With a clear tilt toward defensive U.S. sectors like utilities, consumer staples, and health care, the fund feels more like a shock absorber than a rocket ship.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Cf Industries Holdings | 0.52% | $1.00M | $19.91B | 69.08% | 72 Outperform | |
| United Therapeutics | 0.47% | $896.20K | $23.50B | 74.50% | 79 Outperform | |
| Archer Daniels Midland | 0.46% | $889.00K | $34.64B | 52.56% | 64 Neutral | |
| Murphy USA | 0.46% | $888.47K | $8.47B | 1.23% | 68 Neutral | |
| Whitestone REIT | 0.46% | $882.57K | $1.68B | 12.36% | 77 Outperform | |
| Kroger Company | 0.45% | $854.39K | $47.84B | 16.13% | 56 Neutral | |
| John Wiley Sons Cl A | 0.44% | $853.83K | $1.88B | -16.80% | 69 Neutral | |
| Protagonist Therapeutics | 0.44% | $851.53K | $5.89B | 68.60% | 68 Neutral | |
| UniFirst | 0.44% | $847.29K | $4.75B | 33.64% | 72 Outperform | |
| Sabra Healthcare REIT | 0.44% | $846.72K | $5.20B | 19.19% | 77 Outperform |
SIXL Technical Analysis
Positive
―
Price Trends
38.19
Positive
37.31
Positive
36.74
Positive
Market Momentum
0.06
Positive
42.97
Neutral
9.82
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SIXL, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 39.04, equal to the 50-day MA of 38.19, and equal to the 200-day MA of 36.74, indicating a neutral trend. The MACD of 0.06 indicates Positive momentum. The RSI at 42.97 is Neutral, neither overbought nor oversold. The STOCH value of 9.82 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SIXL.
SIXL Peer Comparison
Comparison Results
Performance Comparison
SIXL
ETC 6 Meridian Low Beta Equity ETF
38.39
1.78
4.86%
ULTY
YieldMax Ultra Option Income Strategy ETF
―
―
―
SYLD
Cambria Shareholder Yield ETF
―
―
―
BGDV
Bahl & Gaynor Dividend ETF
―
―
―
ABFL
Fcf Us Quality Etf
―
―
―
XCHG
AB US Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents